# The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker

Study · id `cardio:ct-nct02030418` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02030418](<https://clinicaltrials.gov/study/NCT02030418>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02030418

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 952 participants.

## Technical summary

Registry record NCT02030418. Allocation not applicable; no masking; primary purpose treatment. Start 2014-02 (actual); primary completion 2015-06 (actual). Results posted on 2025-07-09.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 952 participants (enrolled count; ClinicalTrials.gov record NCT02030418, source copy `cardio:ctgov-nct02030418-2025-07-09`, retrieved 2026-10-26)
- Started: 2014-02 (actual) (ClinicalTrials.gov record NCT02030418, source copy `cardio:ctgov-nct02030418-2025-07-09`, retrieved 2026-10-26)
- Primary completion: 2015-06 (actual) (ClinicalTrials.gov record NCT02030418, source copy `cardio:ctgov-nct02030418-2025-07-09`, retrieved 2026-10-26)
- Completion: 2022-07-15 (actual) (ClinicalTrials.gov record NCT02030418, source copy `cardio:ctgov-nct02030418-2025-07-09`, retrieved 2026-10-26)
- Results first posted: 2025-07-09 (ClinicalTrials.gov record NCT02030418, source copy `cardio:ctgov-nct02030418-2025-07-09`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada (ClinicalTrials.gov record NCT02030418, source copy `cardio:ctgov-nct02030418-2025-07-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02030418-2025-07-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker
- Condition: Bradycardia
- Intervention (Device): Leadless Pacemaker
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Bradycardia (`cardio:bradycardia`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: d6a82ed308da520012d01f9d50d2f9ecb78d3f64d3103ac25b39d5147da1ad09
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
